Literature DB >> 7297152

Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application.

T Takishima, W Hida, H Sasaki, S Suzuki, T Sasaki.   

Abstract

We report a new device for examining the bronchial hyperresponsiveness by directly writing the dose-response curve of respiratory resistance (Rrs) during the continuous inhalation of the methacholine in stepwise incremental concentrations. Respiratory resistance was measured by the forced oscillation method. We found that the Rrs began to increase at a certain threshold concentration of methacholine (bronchial sensitivity) and that it has a curvilinear slope (bronchial reactivity). Subsequent inhalation of the bronchodilator drug returned the Rrs to the control level. Thus, we were able to examine bronchohyperresponsiveness in the patterns of the cumulative dose-response curves of methacholine. All normal subjects were nonresponders; while all of the asthmatic subjects, 63 percent (10) of the 16 patients with chronic bronchitis and 50 percent (7) of the 14 patients with acute bronchitis were responders. The dose-response curves were reproducible. Our device may be clinically applicable for examinations of bronchial hyperresponsiveness and for screening tests.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297152     DOI: 10.1378/chest.80.5.600

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

1.  Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.

Authors:  Y Nakamura; M Hoshino; J J Sim; K Ishii; K Hosaka; T Sakamoto
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  Clinical assessment of airway remodeling in asthma: utility of computed tomography.

Authors:  Akio Niimi; Hisako Matsumoto; Masaya Takemura; Tetsuya Ueda; Yasutaka Nakano; Michiaki Mishima
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

3.  Laryngeal resistance immediately after panting in asthmatic subjects.

Authors:  M Yanai; T Ohrui; K Sekizawa; H Sasaki; T Takishima
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

4.  Bronchial responsiveness in an area of air pollution resulting from wire reclamation.

Authors:  J Y Wang; T R Hsiue; H I Chen
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

5.  Expression of growth factors and remodelling of the airway wall in bronchial asthma.

Authors:  M Hoshino; Y Nakamura; J J Sim
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

6.  Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma.

Authors:  H Matsumoto; A Niimi; M Takemura; T Ueda; M Minakuchi; R Tabuena; K Chin; T Mio; Y Ito; S Muro; T Hirai; S Morita; S Fukuhara; M Mishima
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

7.  Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma.

Authors:  M Honma; G Tamura; K Shirato; T Takishima
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

8.  Elevation of serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in bronchial asthma.

Authors:  A Koizumi; S Hashimoto; T Kobayashi; K Imai; A Yachi; T Horie
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

9.  A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs.

Authors:  M Asano; T Imai; H Inoue; T Masunaga; N Inamura; T Yatabe; J Hiroi; K Nakahara; Y Notsu; T Takishima
Journal:  Agents Actions       Date:  1993-03

10.  Inhalation of calcium channel blocking agents protects against methacholine-induced bronchoconstriction.

Authors:  T Tsuda; M Hatta; K Ishikawa; T Nakagawa; N Mabuchi; H Ando; O Nishida
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.